Meanwhile, participants using Ozempic typically saw weight reductions of about 1015%, with a similar proportion of fat loss
At intake, Pabaus digital forms let practices configure medication reconciliation prompts that surface long-term insulin use before the patient reaches the clinician
New research reveals how GLP-1 medications are reshaping the treatment landscape for conditions affecting the heart, kidney, liver, and more, hinting at a new era in chronic disease management
Plant-based alternatives like agar-agar will set the same way, but they don't provide protein, so you lose the potential fullness benefit
Tirzepatide (Mounjaro, Zepbound): A twincretin, activating both GLP-1 and GIP receptors